The New School
Brooklyn, New York, 10011, United States
Location status: Recruiting
NCT Number: NCT07188467
The goal of this clinical trial is to learn if an adapted version of Self-Help Plus (SH+), a stress management program developed by the World Health Organization, can reduce stress and improve well-being in international students at a U.S. university. The main questions it aims to answer are:
Does SH+ reduce perceived stress, anxiety, and depressive symptoms in international students? Does SH+ improve feelings of social support, self-efficacy, and adjustment in a new cultural environment?
Participants will:
Attend a two-day in-person workshop that includes animated videos, interactive activities, and group discussions.
Complete three surveys (before the workshop, right after, and six weeks later) about stress, mood, and well-being.
Optionally, take part in a short interview to share feedback about their experience.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Brooklyn, New York, 10011, United States
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Digitized SH+ is a group-based, stress management program (adapted from the original Self-Help Plus intervention developed by the World Health Organization), that utilizes animated videos and group discussions to teach participants skills such as Grounding, Unhooking (from difficult thoughts), Being Kind (to self and others), Identifying Values, and Making Room for Difficult Thoughts and Feelings.
Time frame: Change from baseline to 6-week follow-up
Self-reported perceived stress levels. Higher scores indicate greater perceived stress.
Range: 0-40 Higher scores= worse outcome (greater perceived stress) Cutoffs: 0-13 low, 14-26 moderate, 27-40 high
Time frame: Change from baseline to 6-week follow-up
Range: 0-27 Higher scores = worse outcome (greater depression severity). Cutoffs: 1-4 minimal, 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe.
Time frame: Change from baseline to 6-week follow-up
Range: 0-21 Higher scores = worse outcome (greater anxiety severity) Cutoffs: 0-4 minimal, 5-9 mild, 10-14 moderate, 15-21 severe
Time frame: Change from baseline to 6-week follow-up
Range: 0-60 (20 items, scored 0-3) Higher scores = worse outcome (greater loneliness/social isolation).
Time frame: Change from baseline to 6-week follow-up
Range varies (depends on individual): self-reported number of people available for support + satisfaction rating).
Higher scores = better outcome (greater perceived support and satisfaction).
Time frame: Change from baseline to 6-week follow-up
Range: 10-40 (10 items, scored 1-4). Higher scores = better outcome (greater self-efficacy/confidence in coping).
Time frame: Change from baseline to 6-week follow-up
Range: 6-42 (six items, each scored 1-7). Higher scores = worse outcome (greater emotional distress and adjustment difficulty).
Contact information is provided by the study sponsor or research team.
The New School
Other
Implementing a Scalable Mental Health Intervention for International Students: A Pilot Study of Digitized Self-Help Plus
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06633146
Anxiety Disorders, Behavior
Lahti, Finland
View Trial DetailsNCT05451589
Anxiety, Anxiety Disorders
Ann Arbor, Michigan, United States
View Trial DetailsNCT05447312
Behavior, Behavioral Symptoms
Toronto, Ontario, Canada
View Trial DetailsNCT04428112
AIDS Dementia Complex, Alzheimer Disease
San Francisco, California, United States
View Trial Details